First in human phase 1 dose escalation and expansion clinical trial to evaluate the safety, pharmacokinetics and antitumor activity of intravenous AROG4-01 in patients with advanced solid tumors.
Authors: Sonia Macia, Vicente Valenti, Maria Jove, Cinta Hierro, Victor Moreno, Marta Gil-Martin, Emiliano Calvo, Ernest Nadal, Carme Plasencia